Get 20M+ Full-Text Papers For Less Than $1.50/day. Subscribe now for You or Your Team.

Learn More →

Folate receptor α associated with triple-negative breast cancer and poor prognosis.

Folate receptor α associated with triple-negative breast cancer and poor prognosis. Folate receptor α (FRA) has been shown to be selectively expressed in several types of human cancer, including breast cancer. Currently, several FRA target therapies are under intensive study. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Archives of pathology & laboratory medicine Pubmed

Folate receptor α associated with triple-negative breast cancer and poor prognosis.

Archives of pathology & laboratory medicine , Volume 138 (7): -884 – Sep 26, 2014

Folate receptor α associated with triple-negative breast cancer and poor prognosis.


Abstract

Folate receptor α (FRA) has been shown to be selectively expressed in several types of human cancer, including breast cancer. Currently, several FRA target therapies are under intensive study.

Loading next page...
 
/lp/pubmed/folate-receptor-associated-with-triple-negative-breast-cancer-and-poor-q0BQuW0mI4

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

ISSN
0003-9985
DOI
10.5858/arpa.2013-0309-OA
pmid
24028341

Abstract

Folate receptor α (FRA) has been shown to be selectively expressed in several types of human cancer, including breast cancer. Currently, several FRA target therapies are under intensive study.

Journal

Archives of pathology & laboratory medicinePubmed

Published: Sep 26, 2014

There are no references for this article.